Key points are not available for this paper at this time.
Design
Review
Model organism data may aid genomic variant interpretation; leaves open need for human validation before clinical adoption.
The astonishing recent advances in the technology for determining DNA sequences have made personalized genomics a foreseeable reality for the doctor's office. This technology has started a whole new gold rush for human disease gene discovery and produced an onslaught of information that represents a new challenge in personalized medicine: connecting genotype to phenotype. Experimental organisms such as yeast, worms, fruit flies, zebrafish, and mice have long been critical for discovering the molecular mechanisms fundamental to life, thereby providing a shortcut to understanding human biology. The new developments allow these model organisms to also provide key insights into the association of specific genes with human disease.
No takes yet. Share an insight, caveat, or question.
Gitler et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: